Validation of Organotypic Vaginal Tissue Based Assay for Endocrine Disruptors
基于器官型阴道组织的内分泌干扰物测定的验证
基本信息
- 批准号:7270190
- 负责人:
- 金额:$ 21.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-06-01 至 2009-02-28
- 项目状态:已结题
- 来源:
- 关键词:Adrenocortical carcinomaAdvisory CommitteesAffectAgonistAgricultureAndrogensAnimal ModelAnimal TestingAnimalsAnusAreaAromataseAromatase InhibitionBiological AssayBrainCYP19A1 geneCell LineCellsChemical AgentsChemicalsClassCultured CellsDataDevelopmentDinitrobenzenesDisruptionDrug FormulationsDrug IndustryEconomicsEducational process of instructingEmbryoEnd PointEndocrineEndocrine DisruptorsEndocrine disruptionEndocrine systemEnvironmental HealthEnvironmental PollutionEpithelialEpithelial Cell ProliferationEstrogen ReceptorsEstrogensEthical IssuesEvaluationEvolutionExperimental DesignsExperimental ModelsExposure toFetal DevelopmentFluorescence PolarizationFood ProcessingGene ExpressionGoalsGrowthHealthHormonalHormone ReceptorHumanImmune systemIn VitroIndustryLaboratoriesLeadLigandsMCF7 cellMalignant Epithelial CellMalignant NeoplasmsMammary NeoplasmsMethodsModelingMonitorNumbersOperative Surgical ProceduresPaperPesticidesPhasePhytoestrogensProgesterone ReceptorsPublic HealthReproducibilityReproductionResearchResearch Project GrantsRisk AssessmentRodentScreening procedureSensitivity and SpecificitySignal TransductionStratificationStructureSystemTestingThickThyroid GlandTissue ModelTissuesToxic effectTransformed Cell LineUnited States Environmental Protection AgencyUterusVaginaValidationWomen&aposs Healthbasecarcinogenesiscell growthcostenzyme activityestrogenic activityhazardhormone regulationhuman tissuein vitro Assayin vitro Modelin vivokeratinizationmonolayerneoplastic cellreceptorreceptor bindingreceptor expressionreproductiveresponsespecies differencevalidation studies
项目摘要
DESCRIPTION (provided by applicant): Environmental or intentional exposure to a broad variety of chemical agents can alter normal endocrine function. The effects of these "endocrine disruptors" (ED) can have serious health implications including deleterious effects to reproductive capacity, fetal development, the immune system, and carcinogenesis. Current animal tests are expensive, use a large number of animals, and are not necessarily applicable to humans. Thus, a validated, human in vitro method to identify ED is an area of great importance. This research project will develop such a test method. Phase I research will prevalidate MatTek's organotypic vaginal- ectocervical (VEC-FT) tissue model for use in identifying endocrine disruptors (ED). A battery of 25 model compounds with known ED activity will be used. Changes to key hormonal receptors, enzyme activity, tissue structure, proliferation, and gene expression will be monitored. These data will be used to develop a prediction model that will be a sensitive and specific predictor of ED potential. During Phase II, the test method will undergo formal validation in a multi-center, GLP study. The prevalidated in vitro test to be developed for assessing the endocrine disrupting potential of chemicals/ formulations will have enormous environmental and public health significance. Evaluation of endocrine disruptors is important to minimize hazards to humans and wildlife exposed to chemicals that interfere with normal hormonal regulation. The proposed human organotypic tissue based assay will provide a sensitive and specific assay method to screen a large number of endocrine disrupting chemicals at a reduced cost.
描述(由申请人提供):环境或故意接触多种化学剂可以改变正常的内分泌功能。这些“内分泌破坏者”(ED)的影响可能具有严重的健康影响,包括对生殖能力,胎儿发育,免疫系统和致癌作用的有害影响。当前的动物测试很昂贵,使用大量动物,不一定适用于人类。因此,鉴定ED的经过验证的人类体外方法是一个非常重要的领域。该研究项目将开发这种测试方法。第一阶段的研究将使Mattek的细胞型阴道诊断(VEC-FT)组织模型用于识别内分泌干扰物(ED)。将使用25种具有已知ED活动的模型的电池。将监测关键激素受体,酶活性,组织结构,增殖和基因表达的变化。这些数据将用于开发一个预测模型,该模型将是ED电位的敏感且特定的预测指标。在第二阶段,测试方法将在多中心的GLP研究中进行正式验证。为了评估化学/配方的内分泌干扰潜力的开发的体外测试将具有巨大的环境和公共卫生意义。内分泌干扰物的评估对于最大程度地减少对人类的危害和暴露于干扰正常荷尔蒙调节的化学物质的危害。拟议的人体器官组织测定法将提供一种敏感且特定的测定方法,以降低成本筛选大量内分泌破坏化学物质。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Seyoum Ayehunie其他文献
Seyoum Ayehunie的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Seyoum Ayehunie', 18)}}的其他基金
Organotypic Culture Models (OCM) developed from experimental animals for Chemical Toxicity Screening.
器官培养模型 (OCM) 由用于化学毒性筛选的实验动物开发而成。
- 批准号:
10079739 - 财政年份:2020
- 资助金额:
$ 21.18万 - 项目类别:
An In Vitro Human Small Intestine Tissue Model for Drug Permeation Studies
用于药物渗透研究的体外人体小肠组织模型
- 批准号:
9210635 - 财政年份:2014
- 资助金额:
$ 21.18万 - 项目类别:
An In Vitro Human Small Intestine Tissue Model for Drug Permeation Studies
用于药物渗透研究的体外人体小肠组织模型
- 批准号:
8714269 - 财政年份:2014
- 资助金额:
$ 21.18万 - 项目类别:
An In Vitro Human Small Intestine Tissue Model for Drug Permeation Studies
用于药物渗透研究的体外人体小肠组织模型
- 批准号:
9049151 - 财政年份:2014
- 资助金额:
$ 21.18万 - 项目类别:
Use of a CB2 Ligand to prevent HIV-1 Infection and Transmission
使用 CB2 配体预防 HIV-1 感染和传播
- 批准号:
8602723 - 财政年份:2013
- 资助金额:
$ 21.18万 - 项目类别:
Use of a CB2 Ligand to prevent HIV-1 Infection and Transmission
使用 CB2 配体预防 HIV-1 感染和传播
- 批准号:
8681359 - 财政年份:2013
- 资助金额:
$ 21.18万 - 项目类别:
In Vitro Human Tissue Model for Intravaginal Drug Delivery
用于阴道内药物输送的体外人体组织模型
- 批准号:
7910090 - 财政年份:2010
- 资助金额:
$ 21.18万 - 项目类别:
Validation of a Human In Vitro Vaginal Irritation Test
人体体外阴道刺激试验的验证
- 批准号:
7220081 - 财政年份:2007
- 资助金额:
$ 21.18万 - 项目类别:
Validation of Human Vaginal Tissue Assay for Endocrine Disruptors
人体阴道组织内分泌干扰物检测的验证
- 批准号:
8207929 - 财政年份:2007
- 资助金额:
$ 21.18万 - 项目类别:
Validation of a Human In Vitro Vaginal Irritation Test
人体体外阴道刺激试验的验证
- 批准号:
7937022 - 财政年份:2007
- 资助金额:
$ 21.18万 - 项目类别:
相似海外基金
Lung resident Treg suppression of Th2 resident memory T cells in allergic asthma
过敏性哮喘中肺常驻 Treg 对 Th2 常驻记忆 T 细胞的抑制
- 批准号:
10664599 - 财政年份:2023
- 资助金额:
$ 21.18万 - 项目类别:
Characterizing the genetic etiology of delayed puberty with integrative genomic techniques
利用综合基因组技术表征青春期延迟的遗传病因
- 批准号:
10663605 - 财政年份:2023
- 资助金额:
$ 21.18万 - 项目类别:
Social Vulnerability, Sleep, and Early Hypertension Risk in Younger Adults
年轻人的社会脆弱性、睡眠和早期高血压风险
- 批准号:
10643145 - 财政年份:2023
- 资助金额:
$ 21.18万 - 项目类别:
Temporospatial Single-Cell Characterization of Angiogenesis and Myocardial Regeneration in Small and Large Mammals
小型和大型哺乳动物血管生成和心肌再生的时空单细胞表征
- 批准号:
10751870 - 财政年份:2023
- 资助金额:
$ 21.18万 - 项目类别:
ACTS (AD Clinical Trial Simulation): Developing Advanced Informatics Approaches for an Alzheimer's Disease Clinical Trial Simulation System
ACTS(AD 临床试验模拟):为阿尔茨海默病临床试验模拟系统开发先进的信息学方法
- 批准号:
10753675 - 财政年份:2023
- 资助金额:
$ 21.18万 - 项目类别: